Advances in Pharma Business Management and Research : : Volume 1 / / edited by Lars Schweizer, Theodor Dingermann, Otto Quintus Russe, Christian Jansen.
This open access book presents a unique collection of practical examples from the field of pharma business management and research. It covers a wide range of topics such as: 'Brexit and its Impact on pharmaceutical Law - Implications for Global Pharma Companies', 'Implementation of Me...
Saved in:
| HerausgeberIn: | |
|---|---|
| Place / Publishing House: | Cham : : Springer International Publishing :, Imprint: Springer,, 2020. |
| Year of Publication: | 2020 |
| Edition: | 1st ed. 2020. |
| Language: | English |
| Physical Description: | 1 online resource (X, 85 p. 11 illus.) |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| LEADER | 05293nam a22008775i 4500 | ||
|---|---|---|---|
| 001 | 993544272204498 | ||
| 005 | 20230822223102.0 | ||
| 006 | m o d | | ||
| 007 | cr#nn#008mamaa | ||
| 008 | 200219s2020 gw | o |||| 0|eng d | ||
| 020 | |a 3-030-35918-2 | ||
| 024 | 7 | |a 10.1007/978-3-030-35918-8 |2 doi | |
| 035 | |a (CKB)4100000010480423 | ||
| 035 | |a (DE-He213)978-3-030-35918-8 | ||
| 035 | |a (MiAaPQ)EBC6122108 | ||
| 035 | |a (Au-PeEL)EBL6122108 | ||
| 035 | |a (OCoLC)1143625864 | ||
| 035 | |a (oapen)https://directory.doabooks.org/handle/20.500.12854/31058 | ||
| 035 | |a (PPN)24298164X | ||
| 035 | |a (EXLCZ)994100000010480423 | ||
| 040 | |a MiAaPQ |b eng |e rda |e pn |c MiAaPQ |d MiAaPQ | ||
| 041 | 0 | |a eng | |
| 050 | 4 | |a RS380 | |
| 050 | 4 | |a RS190-210 | |
| 072 | 7 | |a TDCW |2 bicssc | |
| 072 | 7 | |a MED072000 |2 bisacsh | |
| 072 | 7 | |a TDC |2 thema | |
| 082 | 0 | 4 | |a 615.19 |2 23 |
| 100 | 1 | |a Schweizer, Lars |4 edt | |
| 245 | 1 | 0 | |a Advances in Pharma Business Management and Research : |b Volume 1 / |c edited by Lars Schweizer, Theodor Dingermann, Otto Quintus Russe, Christian Jansen. |
| 250 | |a 1st ed. 2020. | ||
| 260 | |b Springer Nature |c 2020 | ||
| 264 | 1 | |a Cham : |b Springer International Publishing : |b Imprint: Springer, |c 2020. | |
| 300 | |a 1 online resource (X, 85 p. 11 illus.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | |a Open access |f Unrestricted online access |2 star | ||
| 505 | 0 | |a Chapter 1. Introduction: Trends and developments in the pharmaceutical and life sciences industry -- Chapter 2. Relevance of instruments for measurements of Quality of Life in the AMNOG Context -- Chapter 3. The quality management system for R&D project and portfolio management in a pharmaceutical company -- Chapter 4. Brexit and Its Impact on Pharmaceutical Law - Implications for global pharma companies -- Chapter 5. Implementation of Measurable and Sustainable Actions to Improve Employee’s Engagement and Business Performance - Global Medical Clinical & Regulatory Affairs (GMCRA) – A Role Model at Fresenius Kabi -- Chapter 6. Leadership Models and Work Behavior: An Empirical Analysis of Consequences of Authentic and Transformational Leadership -- Chapter 7. Alliance Management at Merck - Establishing an operational 100-day plan for alliance launches and management. | |
| 520 | |a This open access book presents a unique collection of practical examples from the field of pharma business management and research. It covers a wide range of topics such as: 'Brexit and its Impact on pharmaceutical Law - Implications for Global Pharma Companies', 'Implementation of Measures and Sustainable Actions to Improve Employee's Engagement', 'Global Medical Clinical and Regulatory Affairs (GMCRA)', and 'A Quality Management System for R&D Project and Portfolio Management in a Pharmaceutical Company'. The chapters are summaries of master’s theses by "high potential" Pharma MBA students from the Goethe Business School, Frankfurt/Main, Germany, with 8-10 years of work experience and are based on scientific know-how and real-world experience. The authors applied their interdisciplinary knowledge gained in 22 months of studies in the MBA program to selected practical themes drawn from their daily business. | ||
| 588 | |a Description based on publisher supplied metadata and other sources. | ||
| 546 | |a English | ||
| 650 | 0 | |a Pharmaceutical technology. | |
| 650 | 0 | |a Health care management. | |
| 650 | 0 | |a Health services administration. | |
| 650 | 0 | |a Medical laws and legislation. | |
| 650 | 0 | |a Pharmacy. | |
| 650 | 0 | |a Pharmacy management. | |
| 650 | 1 | 4 | |a Pharmaceutical Sciences/Technology. |0 https://scigraph.springernature.com/ontologies/product-market-codes/B21010 |
| 650 | 2 | 4 | |a Health Care Management. |0 https://scigraph.springernature.com/ontologies/product-market-codes/527030 |
| 650 | 2 | 4 | |a Medical Law. |0 https://scigraph.springernature.com/ontologies/product-market-codes/R16005 |
| 650 | 2 | 4 | |a Pharmacy. |0 https://scigraph.springernature.com/ontologies/product-market-codes/F00008 |
| 650 | 2 | 4 | |a Pharmacoeconomics and Health Outcomes. |0 https://scigraph.springernature.com/ontologies/product-market-codes/H69020 |
| 653 | |a Pharmaceutical Sciences/Technology | ||
| 653 | |a Health Care Management | ||
| 653 | |a Medical Law | ||
| 653 | |a Pharmacy | ||
| 653 | |a Pharmacoeconomics and Health Outcomes | ||
| 653 | |a Pharmaceutics | ||
| 653 | |a Health Care | ||
| 653 | |a Pharmacology | ||
| 653 | |a Pharma Management | ||
| 653 | |a Market Access | ||
| 653 | |a Regulatory Affairs | ||
| 653 | |a Research & Development | ||
| 653 | |a Quality Control | ||
| 653 | |a Open Access | ||
| 653 | |a Industrial chemistry & chemical engineering | ||
| 653 | |a Health economics | ||
| 653 | |a Medical & healthcare law | ||
| 653 | |a Pharmacy / dispensing | ||
| 776 | |z 3-030-35917-4 | ||
| 700 | 1 | |a Schweizer, Lars. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 700 | 1 | |a Dingermann, Theodor. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 700 | 1 | |a Russe, Otto Quintus. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 700 | 1 | |a Jansen, Christian. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 906 | |a BOOK | ||
| ADM | |b 2024-07-16 21:31:42 Europe/Vienna |f system |c marc21 |a 2020-03-09 01:44:44 Europe/Vienna |g false | ||
| AVE | |i DOAB Directory of Open Access Books |P DOAB Directory of Open Access Books |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337594190004498&Force_direct=true |Z 5337594190004498 |b Available |8 5337594190004498 | ||